These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 163506)

  • 1. Thrombin mimetic effects of estrogen: II. Gel filtration and centrifugal evidence for estrogen induced polymerization of fibrinogen derivatives.
    Pilgeram LO; vom dem Bussche G
    Thromb Res; 1975 Jan; 6(1):19-29. PubMed ID: 163506
    [No Abstract]   [Full Text] [Related]  

  • 2. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship.
    Musa BU; Seal US; Doe RP
    J Clin Endocrinol Metab; 1965 Sep; 25(9):1163-6. PubMed ID: 4284083
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oestrogens on human platelet behaviour.
    Elkeles RS; Hampton JR; Mitchell JR
    Lancet; 1968 Aug; 2(7563):315-8. PubMed ID: 4173735
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of ethinyl oestradiol and conjugated equine oestrogens in oophorectomized women.
    Bolton CH; Ellwood M; Hartog M; Martin R; Rowe AS; Wensley RT
    Clin Endocrinol (Oxf); 1975 Mar; 4(2):131-8. PubMed ID: 165913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacodynamic properties of various estrogen formulations.
    Mashchak CA; Lobo RA; Dozono-Takano R; Eggena P; Nakamura RM; Brenner PF; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):511-8. PubMed ID: 6291391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
    Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG
    Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological bases of tissue synthesis using human fibrin glue].
    Pini Prato GP; Cortellini P; Clauser C; Guazzini S
    Minerva Stomatol; 1983; 32(6):903-14. PubMed ID: 6199658
    [No Abstract]   [Full Text] [Related]  

  • 10. A model for the evaluation of estrogens: withdrawal bleeding in ovariectomized rhesus monkeys.
    Schane HP; Anzalone AJ; Potts GO
    Fertil Steril; 1972 Oct; 23(10):745-50. PubMed ID: 4346799
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of reduced human fibrin by polyacrylamide gel electrophoresis (author's transl)].
    Rasche H; Schleyer M; Dietrich M
    Klin Wochenschr; 1974 Mar; 52(5):233-7. PubMed ID: 4835639
    [No Abstract]   [Full Text] [Related]  

  • 13. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
    Caprini JA; Kwaan HC; Zuckerman L; Verduin R
    Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 19. Models proposed for the fibrinogen molecule and for the polymerization process.
    Hudry-Clergeon G; Marguerie G; Pouit L; Suscillon M
    Thromb Res; 1975 Jun; 6(6):533-41. PubMed ID: 1154328
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
    Suontaka AM; Blombäck M; Chapman J
    Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.